Insider Transactions Reported by 14 Insiders of TENAX THERAPEUTICS, INC.

Symbol
TENX on Nasdaq
Location
Chapel Hill, NC

Insiders trading volume in the past year

TENAX THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Thomas Giordano CEO, Director $10,141,768 +$20,000 +0.2% 18 Nov 2025
Stuart Rich Chief Medical Officer, Director $6,045,665 +$96,414 +1.6% 08 Dec 2025
Michael H. Davidson Director $891,886 01 Jul 2025
PROEHL GERALD T Director $746,089 01 Jul 2025
June Sherie Almenoff Director $593,378 +$14,945 +2.6% 17 Nov 2025
Declan Doogan Director $472,252 01 Jul 2025
Robyn Hunter Director $459,200 01 Jul 2025
THOMAS MCGAULEY Interim CFO $58,164 +$58,164 17 Nov 2025
Anthony A. DiTonno CEO, Director 06 Jul 2021
ARMISTICE CAPITAL, LLC Director 18 May 2022
Dellora Investments LP no longer 10% owner 05 Mar 2025
Eliot M. Lurier Interim CFO 29 Oct 2021
James Mitchum Director 10 Jun 2021
LAWRENCE R. HOFFMAN Interim CFO 11 Jan 2024

Recent Insider Transactions by Companies or Individuals for TENAX THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.